---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-009679"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:09:33.898109+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Reneo shareholders elect Dube and Hoelscher as Class I directors, ratify Ernst & Young as auditor

## Summary
- Annual Meeting held June 1, 2022; total outstanding shares 24,458,550.
- Eric M. Dube elected with 18,100,489 votes for, 795,195 against, 2,790,889 broker non-votes.
- Paul W. Hoelscher elected with 18,877,021 votes for, 18,663 against, 2,790,889 broker non-votes.
- Ratification of Ernst & Young as independent auditor for fiscal 2022 approved (21,675,242 for, 11,300 against).

## SEC filing metadata
- accession: 0001558370-22-009679
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/0001558370-22-009679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/rphm-20220601x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-009679
- JSON: https://secwatch.observer/filing/0001558370-22-009679.json
- Plain text: https://secwatch.observer/filing/0001558370-22-009679.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.